Insiders · Profile

Bellon Steven F.

Chief Scientific Officer at Foghorn Therapeutics. Filing since 9 Sep 2024. CIK 0001831749

Company
Date
Role
Action
Shares
Amount
Of holding
9 Sep 2024
Chief Scientific Officer
Sold on a plan
20,000
$190.00K
16.4%
1 decision on file.